• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

United Therapeutics dishes out $210m to settle charity-kickback claims

December 21, 2017 By Sarah Faulkner

Prescription drugsUnited Therapeutics (NSDQ:UTHR) has agreed to pay $210 million to squash claims that it used a charity to illegally cover Medicare patients’ out-of-pocket costs in an attempt to boost sales.

Drug companies are not allowed to subsidize co-pays for people enrolled in Medicare, but they can donate to independent non-profits that provide co-pay assistance.

The settlement revealed that from 2010 to 2014, United Therapeutics made donations to a payment-assistance group called the Caring Voice Coalition. According to the agreement, the drug company received data from Caring Voice Coalition showing how many patients were using United Therapeutics’ blood pressure drugs. That data ultimately determined how much money the pharma company would donate back to the Virginia-based foundation.

A company spokesman told Reuters that the company was glad to see the investigation settled. United Therapeutics disclosed earlier this year that it had the $210 million set aside specifically for the investigation.

Last month, the U.S. Dept. of Health and Human Services’ Office of Inspector General told Caring Voice Coalition that the foundation would lose its authorization.

Caring Voice Coalition is reportedly evaluating its options and will make a choice about its future in January, according to Reuters.

United’s settlement is the first in an industry-wide probe that includes pharma giants like Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ).

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: johnsonandjohnson, Pfizer Inc., United Therapeutics

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS